|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| C07K 16/18 | (2006.01) | ||
| C07K 16/40 | (2006.01) |
| (11) | Number of the document | 3459564 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18185298.9 |
| Date of filing the European patent application | 2011-01-06 | |
| (97) | Date of publication of the European application | 2019-03-27 |
| (45) | Date of publication and mention of the grant of the patent | 2021-10-27 |
| (46) | Date of publication of the claims translation | 2022-03-10 |
| (30) | Number | Date | Country code |
| 29261410 P | 2010-01-06 | US |
| (72) |
SEXTON, Daniel J. , US
VISWANATHAN, Malini , US
|
| (73) |
Takeda Pharmaceutical Company Limited ,
1-1, Doshomachi 4-chome
Chuo-ku, Osaka-shi, Osaka,
JP
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Plazmos kalikreiną surišantys baltymai |
| PLASMA KALLIKREIN BINDING PROTEINS |
| Payment date | Validity (years) | Amount | |
| 2025-12-17 | 16 | 347.00 EUR |
| 2027-01-06 |